What is Protagonist Therapeutics's net income?

Protagonist Therapeutics (PTGX) reported net income of $3.78M in Q1 2026.

How has Protagonist Therapeutics's net income changed year-over-year?

Protagonist Therapeutics's net income increased by 132.5% year-over-year, from -$11.66M to $3.78M.

What is the long-term trend for Protagonist Therapeutics's net income?

Over 3 years (2021 to 2025), Protagonist Therapeutics's net income has grown at a 1.2% compound annual growth rate (CAGR), from -$125.55M to -$130.15M.

What does net income mean?

Net income as the starting point for the indirect method operating cash flow reconciliation.

Protagonist Therapeutics PTGX Net Income

Net Income at other companies

Bristol-Myers SquibbBMY

$2.68B+8.8%

Eli LillyLLY

$7.4B+168%

AmgenAMGN

$1.82B+5.1%

IncyteINCY

$303.33M+91.7%

AbbVieABBV

$697M-45.9%

Apogee Therapeutics, Inc.APGE

——

Other financials

Income statement

See full

Revenue$56.4M+99.0%

Operating income-$3.6M+81.1%

Net income$3.8M+132%

EPS (diluted)$0.05+126%

Balance sheet

See full

Cash & equivalents$193.7M+38.7%

Total debt$9.8M-13.9%

Total equity$655.5M-4.9%

Total assets$697.5M-6.0%

Cash flow

See full

Operating cash flow-$48.9M-139%

CapEx$215.0K-60.6%

Free cash flow-$49.2M-139%

Valuation

See full

Market cap$7.26B+127%

Enterprise value$7.07B+130%

P/S98×+82.6×

Profitability

See full

Operating margin-192.4%-205pp

Net margin-154.9%-182pp

FCF margin-12,264.3%-12,527pp

Returns & leverage

See full

Return on equity-17.1%-26.1pp

Debt / equity0×0.0×

Current ratio17.8×+0.5×

Where this comes from

Reported directly by Protagonist Therapeutics in its filing.

Tagged under the XBRL concept us-gaap:ProfitLoss.

The official record: Protagonist Therapeutics’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about Protagonist Therapeutics's net income.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Protagonist Therapeutics's net income?: Protagonist Therapeutics (PTGX) reported net income of $3.78M in Q1 2026.
How has Protagonist Therapeutics's net income changed year-over-year?: Protagonist Therapeutics's net income increased by 132.5% year-over-year, from -$11.66M to $3.78M.
What is the long-term trend for Protagonist Therapeutics's net income?: Over 3 years (2021 to 2025), Protagonist Therapeutics's net income has grown at a 1.2% compound annual growth rate (CAGR), from -$125.55M to -$130.15M.
What does net income mean?: Net income as the starting point for the indirect method operating cash flow reconciliation.